<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="01/06/2006" creator="Noriko Katsu" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9247567"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9247567</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Organic_compound_other" id="T1" lex="cyclosporin_A">Cyclosporin A</term> interferes with the inducible degradation of <term sem="Organic_compound_other" id="T2" lex="NF-kappa_B_inhibitor"><term sem="Protein_complex" id="T3" lex="NF-kappa_B">NF-kappa B</term> inhibitors</term>, but not with the processing of <term sem="Protein_molecule" id="A4">p105/<term sem="Protein_complex" id="T4" lex="NF-kappa_B1">NF-kappa B1</term></term> in <term sem="Cell_natural" id="T5" lex="T_cell">T cells</term>.</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="E2" />
<cause idref="T1" />
<clue>Cyclosporin A <clueType>interferes</clueType> <linkTheme>with</linkTheme> the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 <clueLoc>in T cells</clueLoc>.</clue>
</event>
<event id="E2">
<type class="Protein_catabolism" />
<theme idref="T3" />
<clue>Cyclosporin A interferes with the inducible <clueType>degradation</clueType> <linkTheme>of</linkTheme> NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.</clue>
</event>
<event assertion="non-exist" id="E3">
<type class="Negative_regulation" />
<theme idref="E4" />
<cause idref="T1" />
<clue>Cyclosporin A <clueType>interferes</clueType> with the inducible degradation of NF-kappa B inhibitors, but not <linkTheme>with</linkTheme> the processing of p105/NF-kappa B1 <clueLoc>in T cells</clueLoc>.</clue>
</event>
<event id="E4">
<type class="Protein_processing" />
<theme idref="A4" />
<clue>Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the <clueType>processing</clueType> <linkTheme>of</linkTheme> p105/NF-kappa B1 in T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term sem="Protein_family_or_group" id="T6" lex="transcription_factor">transcription factor</term> <term sem="Protein_complex" id="T7" lex="NF-kappa_B">NF-kappa B</term> controls the induction of numerous <term sem="DNA_family_or_group" id="T8" lex="cytokine_promoter">cytokine promoters</term> during the activation of <term sem="Cell_natural" id="T9" lex="T_lymphocyte">T lymphocytes</term>.</sentence>
<event id="E5">
<type class="Regulation" />
<theme idref="E6" />
<cause idref="T7" />
<clue>The transcription factor NF-kappa B <clueType>controls</clueType> the induction of numerous cytokine promoters during the activation of <clueLoc>T lymphocytes</clueLoc>.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="T8" />
<clue>The transcription factor NF-kappa B controls the <clueType>induction</clueType> <linkTheme>of</linkTheme> numerous cytokine promoters <clueTime>during the activation of T lymphocytes</clueTime>.</clue>
</event>
<event id="E7">
<type class="Physiological_process" />
<theme idref="T9" />
<clue>The transcription factor NF-kappa B controls the induction of numerous cytokine promoters during the <clueType>activation</clueType> <linkTheme>of</linkTheme> T lymphocytes.</clue>
</event>
<sentence id="S3">Inhibition of <term sem="Other" id="T10" lex="T_cell_activation"><term sem="Cell_natural" id="A1">T cell</term> activation</term> by the <term sem="Organic_compound_other" id="T11" lex="immunosuppressant">immunosuppressants</term> <term sem="Organic_compound_other" id="T12" lex="cyclosporin_A">cyclosporin A</term> (<term sem="Organic_compound_other" id="T13" lex="CsA">CsA</term>) and <term sem="Organic_compound_other" id="T14" lex="FK506">FK506</term> exerts a suppressive effect on the induction of these <term sem="DNA_family_or_group" id="T15" lex="NF-kappa_B-controlled_cytokine_promoter"><term sem="Protein_complex" id="T16" lex="NF-kappa_B">NF-kappa B</term>-controlled <term sem="DNA_family_or_group" id="T17" lex="cytokine_promoter">cytokine promoters</term></term>.</sentence>
<event id="E8">
<type class="Physiological_process" />
<theme idref="A1" />
<clue>Inhibition of T cell <clueType>activation</clueType> by the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event id="E9">
<type class="Negative_regulation" />
<theme idref="E8" />
<cause idref="T13" />
<clue><clueType>Inhibition</clueType> of T cell activation <linkCause>by</linkCause> the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="E8" />
<cause idref="T14" />
<clue><clueType>Inhibition</clueType> of T cell activation <linkCause>by</linkCause> the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event id="E10">
<type class="Negative_regulation" />
<theme idref="E12" />
<cause idref="E9" />
<clue>Inhibition of T cell activation by the immunosuppressants cyclosporin A (CsA) and FK506 <clueType>exerts a suppressive effect</clueType> <linkTheme>on</linkTheme> the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event id="E11">
<type class="Negative_regulation" />
<theme idref="E12" />
<cause idref="E14" />
<clue>Inhibition of T cell activation by the immunosuppressants cyclosporin A (CsA) and FK506 <clueType>exerts a suppressive effect</clueType> <linkTheme>on</linkTheme> the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="T15" />
<clue>Inhibition of T cell activation by the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the <clueType>induction</clueType> <linkTheme>of</linkTheme> these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event id="E13">
<type class="Regulation" />
<theme idref="T17" />
<cause idref="T16" />
<clue>Inhibition of T cell activation by the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the induction of these NF-kappa B-<clueType>controlled</clueType> cytokine promoters.</clue>
</event>
<sentence id="S4">We show for <term sem="Cell_cultured" id="T18" lex="human_Jurkat_T_leukemia_cell">human Jurkat T leukemia cells</term>, as well as <cons sem="(AND Cell_natural Cell_natural)" id="T19" lex="(AND human_primary_T_lymphocyte mouse_primary_T_lymphocyte)"><frag id="F1">human</frag> and <frag id="F2">mouse</frag> <frag id="F3">primary T lymphocytes</frag></cons>, that this inhibitory effect is accompanied by an impaired nuclear translocation of the <term sem="Protein_family_or_group" id="T20" lex="Rel_protein">Rel proteins</term> <term sem="Protein_molecule" id="T21" lex="c-Rel">c-Rel</term>, <term sem="Protein_molecule" id="T22" lex="RelA/p65">RelA/p65</term> and <term sem="Protein_molecule" id="T23" lex="NF-kappa_B1/p50">NF-kappa B1/p50</term>, whereas the nuclear appearance of <term sem="Protein_molecule" id="T24" lex="RelB">RelB</term> remains unaffected.</sentence>
<event id="E15">
<type class="Correlation" />
<theme idref="E10" />
<theme idref="E24" />
<clue>We show for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E10">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event id="E16">
<type class="Correlation" />
<theme idref="E10" />
<theme idref="E25" />
<clue>We show for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E10">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event id="E17">
<type class="Correlation" />
<theme idref="E10" />
<theme idref="E26" />
<clue>We show for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E10">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event id="E18">
<type class="Correlation" />
<theme idref="E11" />
<theme idref="E24" />
<clue>We show for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E11">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event id="E19">
<type class="Correlation" />
<theme idref="E11" />
<theme idref="E25" />
<clue>We show for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E11">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event id="E20">
<type class="Correlation" />
<theme idref="E11" />
<theme idref="E26" />
<clue>We show for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E11">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event id="E21">
<type class="Localization" />
<theme idref="T21" />
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event id="E22">
<type class="Localization" />
<theme idref="T22" />
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event id="E23">
<type class="Localization" />
<theme idref="T23" />
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event id="E24">
<type class="Negative_regulation" />
<theme idref="E21" />
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an <clueType>impaired</clueType> nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E22" />
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an <clueType>impaired</clueType> nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="E23" />
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an <clueType>impaired</clueType> nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event assertion="non-exist" id="E27">
<type class="Negative_regulation" />
<theme idref="E28" />
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains <clueType>unaffected</clueType>.</clue>
</event>
<event id="E28">
<type class="Localization" />
<theme idref="T24" />
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the <clueLoc>nuclear</clueLoc> <clueType>appearance</clueType> <linkTheme>of</linkTheme> RelB remains unaffected.</clue>
</event>
<sentence id="S5"><term sem="Organic_compound_other" id="T25" lex="CsA">CsA</term> does not interfere with the synthesis of <term sem="Protein_family_or_group" id="T26" lex="Rel_protein">Rel proteins</term>, but prevents the inducible degradation of <term sem="Protein_family_or_group" id="T27" lex="cytosolic_NF-kappa_B_inhibitor">cytosolic <term sem="Protein_complex" id="T28" lex="NF-kappa_B">NF-kappa B</term> inhibitors</term> <term sem="Protein_molecule" id="T29" lex="I_kappa_B_alpha">I kappa B alpha</term> and <term sem="Protein_molecule" id="T30" lex="I_kappa_B_beta">I kappa B beta</term> upon <term sem="Other" id="T31" lex="T_cell_activation"><term sem="Cell_natural" id="A2">T cell</term> activation</term>.</sentence>
<event assertion="non-exist" id="E29">
<type class="Negative_regulation" />
<theme idref="E30" />
<cause idref="T25" />
<clue>CsA does not <clueType>interfere</clueType> <linkTheme>with</linkTheme> the synthesis of Rel proteins, but prevents the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event id="E30">
<type class="Gene_expression" />
<theme idref="T26" />
<clue>CsA does not interfere with the <clueType>synthesis</clueType> <linkTheme>of</linkTheme> Rel proteins, but prevents the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event id="E31">
<type class="Negative_regulation" />
<theme idref="E33" />
<cause idref="T25" />
<clue>CsA does not interfere with the synthesis of Rel proteins, but <clueType>prevents</clueType> the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event id="E32">
<type class="Negative_regulation" />
<theme idref="E34" />
<cause idref="T25" />
<clue>CsA does not interfere with the synthesis of Rel proteins, but <clueType>prevents</clueType> the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event id="E33">
<type class="Protein_catabolism" />
<theme idref="T29" />
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the inducible <clueType>degradation</clueType> <linkTheme>of</linkTheme> <clueLoc>cytosolic</clueLoc> NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event id="E34">
<type class="Protein_catabolism" />
<theme idref="T30" />
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the inducible <clueType>degradation</clueType> <linkTheme>of</linkTheme> <clueLoc>cytosolic</clueLoc> NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event id="E47">
<type class="Positive_regulation" />
<theme idref="E33" />
<cause idref="E35" />
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the <clueType>inducible</clueType> degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta <linkCause>upon</linkCause> T cell activation.</clue>
</event>
<event id="E48">
<type class="Positive_regulation" />
<theme idref="E34" />
<cause idref="E35" />
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the <clueType>inducible</clueType> degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta <linkCause>upon</linkCause> T cell activation.</clue>
</event>
<event id="E35">
<type class="Physiological_process" />
<theme idref="A2" />
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell <clueType>activation</clueType>.</clue>
</event>
<sentence id="S6"><term sem="Organic_compound_other" id="T32" lex="CsA">CsA</term> neither inhibits the processing of the <term sem="Protein_molecule" id="T33" lex="NF-kappa_B1_precursor">NF-kappa B1 precursor</term> <term sem="Protein_molecule" id="T34" lex="p105">p105</term> to <term sem="Protein_molecule" id="T35" lex="p50">p50</term>, nor does it &quot;stabilize&quot; the C-terminal portion of <term sem="Protein_molecule" id="T36" lex="p105">p105</term>, <term sem="Protein_molecule" id="T37" lex="I_kappa_B_gamma">I kappa B gamma</term>, which is degraded during <term sem="Protein_molecule" id="T38" lex="p105">p105</term> processing to <term sem="Protein_molecule" id="T39" lex="mature_p50">mature <term sem="Protein_molecule" id="T40" lex="p50">p50</term></term>.</sentence>
<event assertion="non-exist" id="E36">
<type class="Negative_regulation" />
<theme idref="E37" />
<cause idref="T32" />
<clue>CsA neither <clueType>inhibits</clueType> the processing of the NF-kappa B1 precursor p105 to p50, nor does it &quot;stabilize&quot; the C-terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50.</clue>
</event>
<event id="E37">
<type class="Protein_processing" />
<theme idref="T34" />
<product idref="T35" />
<clue>CsA neither inhibits the <clueType>processing</clueType> <linkTheme>of</linkTheme> the <corefTheme>NF-kappa B1 precursor</corefTheme> p105 to p50, nor does it &quot;stabilize&quot; the C-terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50.</clue>
</event>
<event assertion="non-exist" id="E38">
<type class="Negative_regulation" />
<theme idref="E39" />
<cause idref="T32" />
<clue>CsA neither inhibits the processing of the NF-kappa B1 precursor p105 to p50, nor does <corefCause>it</corefCause> <clueType>&quot;stabilize&quot;</clueType> the C-terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50.</clue>
<comment>CAUTION: &quot;stabilize&quot; = inhibition of Protein_catabolism</comment></event>
<event id="E39">
<type class="Protein_catabolism" />
<theme idref="T37" />
<clue>CsA neither inhibits the processing of the NF-kappa B1 precursor p105 to p50, nor does it &quot;stabilize&quot; the <corefTheme>C-terminal portion of p105</corefTheme>, I kappa B gamma, which is <clueType>degraded</clueType> <clueTime>during p105 processing to mature p50</clueTime>.</clue>
</event>
<event id="E40">
<type class="Protein_processing" />
<theme idref="T38" />
<product idref="T39" />
<clue>CsA neither inhibits the processing of the NF-kappa B1 precursor p105 to p50, nor does it &quot;stabilize&quot; the C-terminal portion of p105, I kappa B gamma, which is degraded during p105 <clueType>processing</clueType> to mature p50.</clue>
</event>
<sentence id="S7">These results indicate that <term sem="Organic_compound_other" id="T41" lex="CsA">CsA</term> interferes with a specific event in the <term sem="Other" id="T48">signal</term>-induced <term sem="Other" id="T42">degradation</term> of <term sem="Protein_molecule" id="T43" lex="I_kappa_B_alpha">I kappa B alpha</term> and <term sem="Protein_molecule" id="T44" lex="I_kappa_B_beta">I kappa B beta</term>, but does not affect the processing of <term sem="Protein_molecule" id="T45" lex="NF-kappa_B1/p105"><term sem="Protein_molecule" id="A20">NF-kappa B1</term>/<term sem="Protein_molecule" id="T46" lex="p105">p105</term></term> to <term sem="Protein_molecule" id="T47" lex="p50">p50</term>.</sentence>
<event id="E41">
<type class="Negative_regulation" />
<theme idref="E43" />
<cause idref="T41" />
<clue>These results indicate that CsA <clueType>interferes</clueType> <linkTheme>with</linkTheme> a specific event in the signal-induced degradation of I kappa B alpha and I kappa B beta, but does not affect the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event id="E42">
<type class="Negative_regulation" />
<theme idref="E44" />
<cause idref="T41" />
<clue>These results indicate that CsA <clueType>interferes</clueType> <linkTheme>with</linkTheme> a specific event in the signal-induced degradation of I kappa B alpha and I kappa B beta, but does not affect the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event id="E43">
<type class="Protein_catabolism" />
<theme idref="T43" />
<clue>These results indicate that CsA interferes with a specific event in the signal-induced <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B alpha and I kappa B beta, but does not affect the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event id="E44">
<type class="Protein_catabolism" />
<theme idref="T44" />
<clue>These results indicate that CsA interferes with a specific event in the signal-induced <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B alpha and I kappa B beta, but does not affect the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event assertion="non-exist" id="E45">
<type class="Regulation" />
<theme idref="E46" />
<cause idref="T41" />
<clue>These results indicate that CsA interferes with a specific event in the signal-induced degradation of I kappa B alpha and I kappa B beta, but does not <clueType>affect</clueType> the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event id="E46">
<type class="Protein_processing" />
<theme idref1="T46" idref="A20" />
<product idref1="T47" idref="A20" />
<clue>These results indicate that CsA interferes with a specific event in the signal-induced degradation of I kappa B alpha and I kappa B beta, but does not affect the <clueType>processing</clueType> <linkTheme>of</linkTheme> NF-kappa B1/p105 to p50.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
